NPPA fixes ceiling prices for 77 formulations, non-ceiling prices for 20 packs
The National Pharmaceutical Pricing Authority (NPPA) has revised/fixed the prices of 97 formulation packs as on March 4, 2004. This includes the announcement of ceiling prices for 77 formulation packs and fixation of non-ceiling prices for 20 packs based on the bulk drug insulin, vitamins, combination of cefotaxine sodium and sulbactum sodium, Aspirin and PCMX. The authority has also taken into account the additional packing material cost towards hologram labeling/ROPP caps for prevention of spurious drugs, it is learnt.
The ceiling prices in respect of 77 formulation packs have been fixed under DPCO, 1995 based on glipizide three packs vide S.O. No. 291(E), spironolactone three packs vide S.O. No. 292(E), carbamazepine sixteen packs vide S.O. No. 293(E) & 294(E), doxycycline thirty eight packs vide S.O. No. 295(E), 296(E), 297(E), 298(E) & 299(E) and vitamins based formulations seventeen packs vide S.O. No. 300(E), 301(E), 302(E) & 303(E), dated 4th March, 2004.
The prices of 20 non-ceiling packs based on the bulk drug insulin, vitamins, combination of cefotaxine sodium and sulbactum sodium, Aspirin and PCMX have also been fixed by the NPPA. While fixing these prices, NPPA has also considered the additional packing material cost towards hologram labeling/ROPP caps for prevention of spurious drugs.
NPPA had revised the prices of 34 bulk drugs and derivatives due to reduction in the custom duty and abolition of special additional duty on 3rd March, 2004.
The prices fixed/revised would become effective within 15 days from the date of notification in the official gazette or the receipt of the non-ceiling, price (NCP) Order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995. Necessary revised price list is to be issued by the manufacturers/importers required under sub-paragraph (3) of paragraph 14 of the DPCO, 1995. Accordingly, as per the provision, the revised price list in Form-V of the DPCO is to be furnished by the concerned manufacturer(s) to the Government and NPPA, State Drug Control Authorities and distributors, wholesalers and retailers or any other agent.